Product Overview
TheraPEAK® Nucleofector® Consumables are aimed to support the use of the 4D-Nucleofector® LV Unit as manufacturing equipment in a GMP manufacturing process for advanced therapeutic medicinal products (ATMPs). In such a process, the 4D-Nucleofector® LV Unit and its consumables may be used for non-viral, electroporation-based genetic modification of primary cells, for example T cells or hematopoietic stem cells.
- Sterility (Ph.Eur. 2.6.1)
- Endotoxin (Ph.Eur. 2.6.14)
- Absence of RNAse/DNAse/RNA/DNA (validated methods)
- Sub-visible particles (Ph.Eur. 2.9.19, Method 1)
- Visible particles (Ph.Eur. 2.9.20)
- Chemical and physical parameters (Ph. Eur. methods)
- 1 vial TheraPEAK® P3 Primary Cell Nucleofector® Solution
- 1 vial of TheraPEAK® Supplement 1
- 22.5 mL and 5 mL
- 126 mL and 28 mL (higher volume size to support upstream sample preparation)
Benefits
- Chemically-defined, human and animal-component free composition
- Identity tested, Ph.Eur. grade raw materials
- Aseptically produced at a GMP certified site in a class A environment
- Filled in crimp-sealed glass vials
- Double-layer packaging supporting the clean room cascade
- Validated manufacturing and testing methods
Applications
- Supporting use of 4D-Nucleofector® LV Unit in GMP manufacturing
Storage and Content
- 22.5 mL TheraPEAK® P3 Nucleofector® Solution
- 5 mL TheraPEAK® Nucleofector® Supplement 1